{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:10:45Z","timestamp":1784056245338,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.anaerobe.2020.102245","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T21:05:11Z","timestamp":1595365511000},"page":"102245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017\u20132019"],"prefix":"10.1016","volume":"64","author":[{"given":"Sofia","family":"Maraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria Eirini","family":"Mavromanolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Stafylaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kasimati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2020.102245_bib1","series-title":"Mandell, Douglas, and Bennett's Principle and Practice of Infectious Diseases","first-page":"2923","article-title":"Anaerobic infections: general concepts","author":"Cohen-Poradosu","year":"2019"},{"key":"10.1016\/j.anaerobe.2020.102245_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.11.1.81","article-title":"Gram-positive anaerobic cocci","volume":"11","author":"Murdoch","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.anaerobe.2020.102245_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/cid\/ciu395","article-title":"Antimicrobial resistance and susceptibility testing of anaerobic bacteria","volume":"59","author":"Schuetz","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2020.102245_bib4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/11534490-000000000-00000","article-title":"Anaerobic infections: update on treatment considerations","volume":"70","author":"Nagy","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.anaerobe.2020.102245_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2018.09.009","article-title":"Antimicrobial susceptibility and mechanisms of resistance of Greek Clostridium difficile clinical isolates","volume":"16","author":"Chatedaki","year":"2019","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.anaerobe.2020.102245_bib6","unstructured":"Clinical and Laboratory Standards Institute. Principles and Procedures for Detection of Anaerobes in Clinical Specimens; Approved Guideline, first ed. (M56-A)."},{"key":"10.1016\/j.anaerobe.2020.102245_bib7","series-title":"Wadsworth Anaerobic Bacteriology Manual","first-page":"55","author":"Jousimies-Somer","year":"2002"},{"key":"10.1016\/j.anaerobe.2020.102245_bib8","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 30th ed. (M100-S30)."},{"key":"10.1016\/j.anaerobe.2020.102245_bib9","series-title":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables\u00a0for Interpretation of MICs and Zone Diameters","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2020"},{"key":"10.1016\/j.anaerobe.2020.102245_bib10","author":"Food and Drug Administration (Fda)"},{"key":"10.1016\/j.anaerobe.2020.102245_bib11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2020.102245_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anaerobe.2017.04.007","article-title":"Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a Slovenian tertiary-care hospital in 2015","volume":"47","author":"Jeverica","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib13","first-page":"308023","article-title":"Antimicrobial susceptibility patterns of anaerobic bacteria in Victoria, Australia","author":"Teng","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.anaerobe.2020.102245_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.anaerobe.2018.04.009","article-title":"In\u00a0vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial","volume":"51","author":"Rodloff","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib15","doi-asserted-by":"crossref","first-page":"102111","DOI":"10.1016\/j.anaerobe.2019.102111","article-title":"Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI Study","volume":"61","author":"Veloo","year":"2020","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/jac\/dkl052","article-title":"Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003","volume":"57","author":"Roberts","year":"2006","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2020.102245_bib17","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1128\/AAC.46.9.2908-2913.2002","article-title":"High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan","volume":"46","author":"Teng","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2020.102245_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10096-008-0624-1","article-title":"Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology","volume":"28","author":"Glupczynski","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2020.102245_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3343\/alm.2015.35.5.479","article-title":"Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012","volume":"35","author":"Lee","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.anaerobe.2020.102245_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.anaerobe.2014.08.012","article-title":"Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data","volume":"31","author":"Jamal","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.anaerobe.2014.05.015","article-title":"Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011","volume":"28","author":"Marchand-Austin","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2007.11.006","article-title":"European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci","volume":"31","author":"Brazier","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.anaerobe.2020.102245_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3343\/alm.2019.39.2.190","article-title":"Antimicrobial susceptibility patterns of anaerobic bacterial clinical isolates from 2014 to 2016, including recently named or renamed species","volume":"39","author":"Byun","year":"2019","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.anaerobe.2020.102245_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkh270","article-title":"Nitroimidazole resistance genes (nimB) in anaerobic Gram-positive cocci (previously Peptostreptococcus spp.)","volume":"54","author":"Theron","year":"2004","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2020.102245_bib25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10096-020-03852-5","article-title":"Propionibacterium\/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital","volume":"39","author":"Broly","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2020.102245_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1586\/14787210.2015.1040765","article-title":"Antibiotic resistance to Propionibacterium acnes: worldwide scenario, diagnosis and management","volume":"13","author":"Sardana","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.anaerobe.2020.102245_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1469-0691.2004.01055.x","article-title":"ESCMID study group on antimicrobial resistance in anaerobic bacteria. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes","volume":"11","author":"Oprica","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2020.102245_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anaerobe.2004.02.002","article-title":"Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm","volume":"10","author":"Oprica","year":"2004","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13555-019-00320-7","article-title":"Antimicrobial susceptibility, biotypes and phylotypes of clinical Cutibacterium (Formerly Propionibacterium) acnes strains isolated from acne patients: an observational study","volume":"9","author":"Zhang","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.anaerobe.2020.102245_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/1346-8138.13149","article-title":"Multicenter cross-sectional observational study on antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris","volume":"43","author":"Fan","year":"2016","journal-title":"J.\u00a0Dermatol."},{"key":"10.1016\/j.anaerobe.2020.102245_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anaerobe.2016.07.003","article-title":"Changes in the antibiotic susceptibility of anaerobic bacteria from 2007\u20132009 to 2010\u20132012 based on the CLSI methodology","volume":"42","author":"Hastey","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jac\/dkv347","article-title":"Resistance patterns in clinical isolates of pathogenic Actinomyces species","volume":"71","author":"Steininger","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2020.102245_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmi.2017.10.008","article-title":"The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014","volume":"24","author":"Freeman","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.anaerobe.2020.102245_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1099\/jmm.0.000646","article-title":"Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China","volume":"67","author":"Chen","year":"2018","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2020.102245_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.anaerobe.2017.09.003","article-title":"Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: a prospective multicenter surveillance study in Japan","volume":"48","author":"Yunoki","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5812\/ircmj.5189","article-title":"Antimicrobial susceptibility of Clostridium difficile clinical isolates in Iran","volume":"15","author":"Goudarzi","year":"2013","journal-title":"Iran Red Crescent Med"},{"key":"10.1016\/j.anaerobe.2020.102245_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/fpd.2013.1648","article-title":"Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas","volume":"11","author":"Norman","year":"2014","journal-title":"Foodb. Pathog. Dis."},{"key":"10.1016\/j.anaerobe.2020.102245_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anaerobe.2019.05.007","article-title":"Antimicrobial susceptibility and clinical findings of significant anaerobic bacteria in southern Spain","volume":"59","author":"Cobo","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib39","doi-asserted-by":"crossref","first-page":"102050","DOI":"10.1016\/j.anaerobe.2019.06.003","article-title":"Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017","volume":"60","author":"Tickler","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.anaerobe.2019.102072","article-title":"Increasing antibiotic resistance in Clostridioides difficile: a systematic review and meta-analysis","volume":"58","author":"Saha","year":"2019","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib41","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.anaerobe.2020.102167","article-title":"Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland","volume":"62","author":"Lachowicz","year":"2020","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2020.102245_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jiac.2019.07.018","article-title":"Antimicrobial susceptibility surveillance of obligate anaerobic bacteria in the Kinki area","volume":"25","author":"Shimura","year":"2019","journal-title":"J.\u00a0Infect. Chemother."},{"key":"10.1016\/j.anaerobe.2020.102245_bib43","first-page":"310-311","article-title":"Activity of tigecycline against multidrug-resistant clinical isolates of Clostridium spp. from Europe","volume":"35","author":"Hawser","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.anaerobe.2020.102245_bib44","doi-asserted-by":"crossref","first-page":"102136","DOI":"10.1016\/j.anaerobe.2019.102136","article-title":"Microbiological characteristics of human and animal isolates of Clostridioides difficile in Italy: results of the Istituto Superiore di Sanit\u00e0 in the years 2006-2016","volume":"61","author":"Barbanti","year":"2020","journal-title":"Anaerobe"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996420301013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996420301013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:38:21Z","timestamp":1761035901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996420301013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":44,"alternative-id":["S1075996420301013"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2020.102245","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility patterns of clinically significant Gram-positive anaerobic bacteria in a Greek tertiary-care hospital, 2017\u20132019","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2020.102245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102245"}}